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Background: Staphylococcus aureus strains with distinct genetic backgrounds have shown different virulence in
animal models as well as associations with different clinical outcomes, such as causing infection in the hospital or
the community. With S. aureus strains carrying diverse genetic backgrounds that have been demonstrated by gene
typing and genomic sequences, it is difficult to compare these strains using mammalian models. Invertebrate host
models provide a useful alternative approach for studying bacterial pathogenesis in mammals since they have
conserved innate immune systems of biological defense. Here, we employed Drosophila melanogaster as a host
model for studying the virulence of S. aureus strains.
Results: Community-associated methicillin-resistant S. aureus (CA-MRSA) strains USA300, USA400 and CMRSA2 were
more virulent than a hospital-associated (HA)-MRSA strain (CMRSA6) and a colonization strain (M92) in the D.
melanogaster model. These results correlate with bacterial virulence in the Caenorhabditis elegans host model as
well as human clinical data. Moreover, MRSA killing activities in the D. melanogaster model are associated with
bacterial replication within the flies. Different MRSA strains induced similar host responses in D. melanogaster, but
demonstrated differential expression of common bacterial virulence factors, which may account for the different
killing activities in the model. In addition, hemolysin α, an important virulence factor produced by S. aureus in
human infections is postulated to play a role in the fly killing.
Conclusions: Our results demonstrate that the D. melanogaster model is potentially useful for studying S. aureus
pathogenicity. Different MRSA strains demonstrated diverse virulence in the D. melanogaster model, which may be
the result of differing expression of bacterial virulence factors in vivo.
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Staphylococcus aureus is an important human pathogen,
causing a wide range of diseases from skin and soft tissue
infections to life threatening sepsis [1]. Methicillin-resistant
S. aureus (MRSA), which causes infections in hospitals and
in the community, has become a major public health prob-
lem worldwide. MRSA strains can be classified into differ-
ent clonal groups and subgroups according to their* Correspondence: kzhang@ucalgary.ca
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reproduction in any medium, provided the orgenotypic characteristics. Epidemiologic data have indicated
that certain strains are more commonly associated with in-
vasive infections than others [2]. Experimental studies using
human neutrophils and a mouse model suggested that
community-associated MRSA (CA-MRSA) strains are
more virulent than hospital-associated MRSA (HA-MRSA)
strains [3]. For CA-MRSA strains, USA300 showed higher
virulence than USA400 in a rat pneumonia model [4].
These findings suggest that the virulence of S. aureus
strains in the animal models may correlate with the clinical
outcomes. However, to date, there are 17 major clonal com-
plexes and many more subgroups identified from the
S. aureus isolates collected worldwide, including MSSA. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Wu et al. BMC Microbiology 2012, 12:274 Page 2 of 10
http://www.biomedcentral.com/1471-2180/12/274and MRSA strains, and more are expected to be identified
[5]. Given this complexity it is difficult to compare the
virulence of these strains using mammalian models.
We previously utilized the nematode, C. elegans, as a
host model to analyze the virulence of major local
clinical MRSA isolates, including those belonging to
USA300, USA400, and Canadian epidemic strains MRSA
2 (CMRSA2) and CMRSA6. Our results demonstrated
that CA-MRSA strains are more virulent than HA-MRSA
strains [6]. Moreover, the virulence of MRSA in the
C. elegans model correlated well with the isolation of
MRSA from clinically relevant invasive anatomic sites in
humans [6,7], suggesting that the invertebrate model
could be a useful tool for studying S. aureus pathogenicity.
Drosophila melanogaster, the fruit fly, has a number of
characteristics which make it a suitable model for study-
ing host interactions with important human pathogens.
Drosophila has a complex innate immune system and
compared with the innate immunity of C. elegans. The
fly has the toll and immune deficiency (IMD) signalling
pathways that act in response to bacterial and fungal
infections, which are homologous to the toll-like recep-
tor (TLR) and tumour necrosis factor receptor (TNFR)
pathways in mammals [8]. Drosophila has been used as
an infection model for different bacterial species, inclu-
ding Pseudomonas aeruginosa [9,10], Mycobacterium
marinum [11], Listeria monocytogenes [12], and Salmonella
[13]. To date, a few lab strains of S. aureus have been ana-
lyzed using a fly model and demonstrated virulence [14],
suggesting that D. melanogaster could be adapted as a con-
venient high-thoughput model for S. aureus infection.
In this study, we employed D. melanogaster as a host
model to study the virulence of our major local MRSA
epidemic strains with different genetic backgrounds.
These strains exhibited differing degrees of virulence,
with USA300, USA400, and CMRSA2 being more viru-
lent than CMRSA6 and an M92 colonization strain,
which correlated with human clinical data and with the
C. elegans model for these same strains [6]. We observed
that the high virulence strains replicated and spread sys-
temically within the fly in a significantly greater manner
than they did in the low virulence strains, resulting in
greater killing activities. This is thought to be due to
greater expression of bacterial virulence factors. Our
results suggest that the Drosophila fly model could be
another useful invertebrate model for MRSA pathoge-
nesis, and host immunity because of its well characte-
rized innate immune system.
Methods
Bacterial strains and growth conditions
The Canadian epidemic MRSA reference strains CMRSA2,
6, 7, and 10 were provided by the National Microbiology
Laboratory, Health Canada, Winnipeg, Canada [15]. StrainM92 is a strain which has only been associated with
colonization of the nares in hospital staff at our local hos-
pitals, but has not been associated with infection over the
course of many years. The clinical isolates used in this
study were identified by standard procedures as previously
described [6].
Maintenance of D. melanogaster and fly killing assay
D. melanogaster Canton S flies were maintained at room
temperature on standard cornmeal agar. The feeding
assay was performed as previously described [16]. The
pricking assay was modified from the method developed
by Fehlbaum et al. [17]. Briefly, healthy 2–5 day-old
female flies were anesthetised on ice and carefully
pricked in the dorsal thorax with a 27.5-gauge needle
(BD Biosciences) which had been dipped into bacterial
cultures adjusted to a concentration of ~8 × 108 CFU/ml
in brain-heart infusion (BHI) broth. Fly survival was
monitored and recorded from 12 to 72 hours post inocu-
lation. Survival curves were generated by the Kaplan-
Meier method, and statistical significance was calculated
by log-rank test using Prism 5 (GraphPad Software, Inc.).
Bacterial in vitro growth curve
Overnight bacterial cultures were diluted (1:1000) in fresh
BHI broth or M9 minimal salt medium (BD Biosciences),
with 200μl loaded onto a 96-well plate. Each well was co-
vered with 50 μl of mineral oil to prevent evaporation.
The growth curves of bacterial cultures at 25°C, which
mimics the temperature inside fly body, were monitored
photometrically by reading the optical density at 600nm
using an automatic optical density measuring machine
(1420 Multilabel Counter VICTOR, Perkin Elmer).
Bacterial in vivo growth inside flies
Bacterial replication was monitored throughout the fly
pricking experiments, and only the live flies were
assessed. In order to enumerate viable bacteria in the
whole fly at 1, 6, 18, and 24 hours post infection, 8
infected flies were harvested, and the whole flies were
homogenized using pestles (DiaMed), and the bacterial
number per fly was enumerated. In order to enumerate
the bacteria present in specific body parts (i.e. crop,
head, leg, and wing), 8–10 infected flies were harvested
and dissected at 18 hours post infection, with the spe-
cific body parts collected into 100μl phosphate buffered
saline (PBS) followed by homogenization. The quantita-
tive bacterial counts in the different body parts of each fly
were enumerated. For both the whole fly and body part
harvesting, the homogenate was re-suspended in 1 ml of
PBS, and 100μl of 10-fold serial dilutions were plated onto
tryptic soy agar (TSA) with ampicillin (50μg/ml). Colonies
were counted following overnight incubation at 37°C.
The Mann–Whitney test was performed to determine
Table 1 Primers used for qRT-PCR analysis
Primers Sequence (5' to 3') Ref
rp49 F GACGCTTCAAGGGACAGTATCTG [18]
rp49 R AAACGCGGTTCTGCATGAG [18]
dpt- F GCTGCGCAATCGCTTCTACT [18]





hla-F CTGATTACTATCCAAGAAATTCGATTG This study
hla-R CTTTCCAGCCTACTTTTTTATCAGT This study
hlg-F ATAGAAGATATCGGCCAAGG This study
hlg-R TTGCATCTTAACAACTAGGGC This study
sak-F GACGCGAGTTATTTTGAACC This study
sak-R TCTTTTGTAAGTGTAGTCCCAGG This study
hysA-F GTTTGATGCTACA GAGAAAGAGG This study
hysA-R CTGCGATTTTCTCAATATTACG This study
sspA- F GGGT TATTAGGTTG GTCATCG This study
sspA-R AAGTGATCGGAATTCATTGG This study
gyrB-F ATCGACTTCAGAGAGAGGTTTG [19]
gyrB-R CCGTTATCCGTTACTTTAATCCA [19]
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For microscopic examination of the whole fly, the
infected flies at 18 hours post infection were fixed in 10%
neutral-buffered formalin and sent to the Histopathology
Laboratory at the Faculty of Veterinary Medicine,
University of Calgary, for processing, sectioning, and
Gram staining.
RNA isolation and reverse transcription
For bacterial virulence gene expression in vitro, 0.5-ml
of bacterial culture at the mid-log phase (OD600 ~0.6)
and the stationary phase (OD600 ~ 4.5 for CMRSA2 and
CMRSA6, and OD600 ~ 5.0 for USA300, USA400 and
M92, based on the bacterial growth curve measurements
for each strain) were aliquoted. The total RNA was
extracted using TRIzol (Invitrogen). For host antimicrobial
peptide (AMP) gene expression or in vivo bacterial viru-
lence gene expression, total RNA from five flies chosen
randomly at 6, 18, and 24 hours post-infection were
extracted using TRIzol, as previously described [18].
Genomic DNA was eliminated by DNase I (Amp Grade,
Invitrogen) treatment, and cDNA synthesis was performed
with an iScript cDNA Synthesis kit (Bio-Rad, USA).
Quantitative real-time PCR
qRT-PCR was performed using iQ SYBR Green Supermix
(Bio-Rad,USA) on a CFX96 Real-Time Detection System
(Bio-Rad, USA). For host gene expression, the thermal
cycle conditions were performed as described previously
[18]. The expression levels of Drosomycin, Diptericin, and
Cecropin A1 at 18 hours post infection in the flies were
normalized to the house keeping gene ribosome protein
49 (rp49) [18]. For bacterial gene expression, the expres-
sion levels of hla, hlg, sak, sspA, and hysA in different
strains growing in BHI broth at mid-log and stationary
phases and inside the flies were normalized to the control
gene, gyrB, encoding DNA topoisomerase subunit B [19].
All primers used for qRT-PCR are listed in Table 1. Rela-
tive target gene expression was calculated according to
the ΔΔCt method, in which the fold difference in expres-
sion was 2-ΔΔCt [20]. The experiments were repeated at
least three times. Student’s t-test analysis was performed
to determine significant differences of the host gene
expressions in response to different MRSA strains and the
virulence gene expression among different strains.
Results
MRSA strains with greater propensity to cause clinically
invasive human infection showed increased fly killing
activities
We tested both feeding and pricking methods to com-
pare the virulence of clinical MRSA strains in the fly
model. Feeding experiments did not show significant dif-
ferences among these strains in terms of the killingactivities (data not shown). However, pricking experi-
ments demonstrated that different clinical MRSA strains
had distinct killing activities. Flies injected with plain
BHI broth were included as a negative control, for which
no flies were killed during the whole period of the
experiment. USA300, USA400 and CMRSA2, previously
shown to have a greater propensity to cause clinically
invasive human infection [6], demonstrated high killing
activities, with 51.4%, 60.3% and 72.8% of flies dead at 36
hours, and 83.5%, 84.9% and 97.7% of flies dead at 72
hours, respectively. No significant differences were
observed between these strains (p>0.05) (Figure 1A).
However, CMRSA6 showed significantly lower killing ac-
tivity (p<0.05), whereby only 15.3% of flies died at 36
hours and 71.8% at 72 hours. Moreover, the colonization
strain M92 showed significantly lower killing activity com-
pared with CMRSA6 (p<0.05). To further confirm the dif-
ferential fly killing activities described above, two
additional clinical isolates from each clonal group with
similar genetic backgrounds were tested. It was noted that
all isolates belonging to the same clonal group demon-
strated similar killing activities (p>0.05) (Figure 1B-E).
However, all the members of each clonal group from
USA300, USA400 and CMRSA2 showed significant differ-
ences to all the members of CMRSA6 group (all p<0.05),
but no significant differences were observed between all
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Figure 1 MRSA strains demonstrated different killing activities against D. melanogaster. (A) Kaplan-Meier survival plots of Drosophila
pricked with the representative clinical MRSA strains. (B-E) Three clinical isolates within a clonal group demonstrated similar levels of killing
activity: (B) USA300 isolates (2406, CMRSA10, 5391); (C) USA400 isolates (CMRSA7, 8830, 2772); (D) CMRSA2 isolates (CMRSA2, 849, 382); (E)
CMRSA6 isolates (1777, CMRSA6, 086).
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confirmed that USA300, USA400, and CMRSA2 strains
were highly virulent in the fly model, while CMRSA6 and
M92 were considered to be of lower virulence.
MRSA proliferation and dissemination correlated with fly
killing activity
We have observed that USA300, USA400, and CMRSA2
were more virulent than CMRSA6 and M92 in the fly
model. To investigate whether the growth rate inside the
flies was associated with the fly killing activity, we mea-
sured the bacterial growth in vitro (M9 minimal medium
and BHI broth, 25°C) and in vivo (inside the fly).
The high virulence strains USA300 and USA400 had the
highest growth rates in both BHI broth and M9 minimal
medium; but CMRSA2 had a lower growth rate and simi-
lar virulence to USA300 and USA400 in the fly model
(Figure 2A and B), indicating that the growth rate in vitro
was not associated with virulence in the fly model.
On the other hand, in vivo results indicated that the
high virulence strains had a higher growth rate than the
low virulence strains in vivo. At 1 hour post infection,
similar bacterial counts (0.43 × 104 to 0.83 × 104 CFU/fly)
were observed for all MRSA strains (Figure 2C). The
bacterial counts per fly increased by time indicating that
bacterial replication was occurring and 1.8 × 104 - 4.2 × 104CFU/fly were observed for all strains at 6 hours. Following
the 6 hour mark, the high virulence strains, USA300,
USA400 and CMRSA2, grew exponentially and the viable
bacterial counts were 0.77 × 108-1.7 × 108 CFU/fly by
18 hours. The low virulence strains grew more slowly and
by 18 hours the viable bacterial counts were 0.72 × 106
CFU/fly for CMRSA6 and 1.4 × 106 CFU/fly for M92. A
significant difference was observed between the high viru-
lence strains and the low virulence strains (p=0.003). At 24
hours post infection with the high virulence strains, dead
flies were excluded from the experiment. With the survi-
ving flies, the viable bacterial concentration per fly was
approximately 107 CFU/fly for USA300 and CMRSA2
infected flies, and 108 CFU/fly for USA400. With CMRSA6
and M92 infected flies, the bacterial counts were about
3.0 × 106 CFU/fly at 24 hours.
We further investigated whether the growth rate inside
flies was associated with bacterial dissemination within
the fly, or with a localized infection, depending on the
strain of MRSA. The bacterial loads in different body
parts (i.e. crop, head, wing and leg) of flies infected with
the high and low virulence strains were determined. We
found that bacterial cells were present in all body parts
for all strains. However, the low virulence strains had
lower numbers of bacteria in each body part compared
to the high virulence strains. In the crops, more bacteria
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Figure 2 MRSA proliferation correlated with fly killing activity. Growth curves of MRSA strains in M9 minimal medium (A) and brain heart
infusion (BHI) broth (B) at 25°C for 24 hrs. (C) Growth of MRSA strains within the flies for 24 hrs. A batch of live flies was harvested at 1, 6, 18, and
24 hours post infection and CFU/fly was determined. (D-G) Bacterial counts in different body parts from the flies infected with different MRSA
strains at 18 hours post infection: (D) crop; (E) head; (F) wing; (G) leg. The asterisk indicates a statistically significantly difference (p < 0.05)
between groups of the high virulence strains and the low virulence strains in bacterial counts in different body parts (Mann–Whitney test). (H-M)
Microscopic examination of representative histopathological sections of BHI broth-injected (control) flies (H,K), and M92 (I, L) and USA300-2406
(J, M) infected flies, low (4X) and high magnification (100X) respectively.
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(1.1 × 104 CFU/crop), and CMRSA2 (3.5 × 103 CFU/crop)
infected flies than CMRSA6 (1.6 × 103 CFU/crop) and
M92 (1.2 × 103 CFU/crop) infected flies at 18 hourspost infection. Similarly, there were higher numbers
of USA300, USA400 and CMRSA2 (>3.3 folds) com-
pared with CMRSA6 and M92 in the head, leg, and
wing (Figure 2D-G). There were significant differences
Wu et al. BMC Microbiology 2012, 12:274 Page 6 of 10
http://www.biomedcentral.com/1471-2180/12/274(p<0.0001) between the groups of the high virulence
strains and the low virulence strains in terms of the
bacterial load in these body parts.
To further demonstrate the difference in the in vivo
growth rates between the high virulence and low viru-
lence strains, we examined the flies infected with
USA300-2406 (high virulence) and M92 (low virulence)
by histopathology. As shown in Figure 2H-M, the M92
infected fly had a small number of Gram positive cocci
in the dorsal thorax, while the USA300 infected fly had
significantly greater concentration, as well as in other
body parts compared with the M92 infected fly and the
controls.
Host innate immune response to MRSA infection
Drosophila mounts innate responses following bacterial
challenge by secreting different antimicrobial peptides
(AMPs), such as drosomycin, diptericin, and cecropin
A1. We measured the fly host immune response to dif-
ferent MRSA strains in order to determine whether this
response correlates with the observed fly killing activity.
The induction of drosomycin, diptericin and cecropin
A1 in the infected flies was shown as a fold change of
transcriptional level relative to the constitutive transcrip-
tional level of these genes in control flies pricked with
BHI broth. For all strains, the transcription of all three
AMPs was activated post infection. No significant differ-
ence in drosomycin or diptericin gene expression was
observed among the flies infected with the various
strains. (Figure 3A and B). There was a marked differ-
ence noted for cecropin A1 gene expression among the
various strains. The transcriptional level increased 37- to
54-fold for all flies 6 hours post infection, and 146 to
1253-fold at 18 hours (Figure 3C). At 18 hours, the tran-
scriptional level of cecropin A1 was 146-fold higher in













Figure 3 Host immune responses to MRSA infection. D. melanogaster A
by qRT-PCR as fold change of the transcriptional level in the MRSA infected
(B) Diptericin induction; (C) Cecropin A1 induction. The asterisk indicates a
MRSA strains in inducing host Cecropin A1 expression at 18 hours post infesignificantly lower than the fold increase seen in the flies
infected with the other strains (642–1253 fold, p=0.03).
This difference was also observed at 24 hours post infec-
tion, although no statistical difference was observed.
Our results demonstrated that different MRSA strains
induced similar levels of fly innate immune responses
except for M92 which induced much less cecropin A1.
Different MRSA strains have distinct bacterial virulence
gene expression patterns
Since different MRSA strains induced similar host
responses, we determined whether the differences in
S. aureus virulence seen in the fly model could be
accounted for by differing bacterial virulence gene tran-
scriptional levels. We compared the transcriptional levels
of 5 common virulence genes using qRT-PCR. These genes
included 2 haemolysins (hemolysin α and γ; hla and hlg)
and 3 exoenzymes (hyaluronidase, staphylokinase, and V8
protease; hysA, sak and sspA) in MRSA strains using qRT-
PCR. Due to the fact that the quantity of RNA was low at
6 hours and most flies were dead at 24 hours post infec-
tion, only bacterial RNA at 18 hours was harvested.
The first comparison that was made for virulence gene
expression was between the mid-log and stationary
phases of bacteria grown in BHI broth. The expressions
of hla, hlg and sak were higher in the stationary phase
than in the mid-log phase for all strains (Figure 4A),
which is consistent with previous studies [21-23]. The
expressions of sspA and hysA were higher in the mid-log
phase for some strains, suggesting that the expression of
these genes varied among strains. We subsequently com-
pared the virulence gene expression of S. aureus strains
against that of M92 in vitro (Figure 4B). All strains were
found to have lower hla expression than M92 in vitro,
but varied in the expression of other genes, with no











MP gene induction at 6, 18 and 24 hour post infection was calculated
flies relative to the BHI broth-injected flies: (A) Drosomycin induction;
statistically significantly difference (p = 0.03) between M92 and other
ction (Student’s t-test).
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*p≤0.038
*p≤0.007
Figure 4 Comparison of 5 virulence gene expression profiles between different MRSA strains. (A) Fold-change in the transcriptional level
for each gene in MRSA at stationary phase relative to the level in bacteria at mid-log phase in vitro (BHI broth); (B) Fold-change in the
transcriptional level for each gene of MRSA strains relative to the level of M92 at mid-log phase in vitro (BHI broth); (C) Fold-change in the
transcriptional level of each gene in MRSA strains relative to the level of M92 at 18 hour in the flies post infection (in vivo). The asterisk indicates a
statistically significantly difference (p < 0.05) of the in vivo virulence gene expression in the MRSA strains as compared with M92 (Student’s t-test).
Hemolysin α (hla): USA300 vs M92, p=0.0013; USA400 vs M92, p=0.038; and CMRSA2 vs M92, p=0.0015. Staphylokinase (sak): USA300 vs M92,
p=0.006; USA400 vs M92, p=0.007; CMRSA2 vs M92, p=0.0698.
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was significantly higher in all high virulence strains
(USA300, USA400 and CMRSA2; p values: 0.0013, 0.038
and 0.0015, respectively) but not in the low virulence
strain CMRSA6 as compared with M92 (Figure 4C). High
in vivo expression of sak and sspA were also observed in
the high virulence strains but not all of them exhibited sig-
nificant difference (sak, p values: 0.006, 0.007 and 0.0698
for USA300, USA400 and CMRSA2, respectively; sspA, all
p > 0.05) (Figure 4C). The other genes displayed different
gene expression patterns in different strains without cor-
relation with fly killing activity. CMRSA6, a low virulence
strain, showed lower in vivo gene expression compared
with M92 for all genes tested.
Discussion
Needham and co-workers [14] have shown that a limited
number of S. aureus lab strains caused fly death follow-
ing injection of bacteria into the dorsal thorax of the
flies, suggesting it is a useful model for high-throughput
analysis of S. aureus virulence determinant. In this study,
we compared the virulence of MRSA strains with differ-
ent genetic backgrounds using the fly model and demon-
strated that they had different fly killing activities, where
USA300, USA400, and CMRSA2 strains had greater kill-
ing activities compared to CMRSA6 and M92. We had
previously described the nematocidal activity of these
strains in the C. elegans host model, in which USA300,
USA400, and CMRSA2 were demonstrated to be viru-
lent, but CRMSA6 and M92 were non-virulent. [6]. The
results from this study further support the notion that
innate immunity is conserved between C. elegans and
D. melanogaster. C. elegans and D. melanogaster are
evolutionarily closely related and have been shown topossess homologous proteins in the innate immunity,
such as p38 MAPK [24],
It has been demonstrated that P. aeruginosa is capable
of invading and degrading fly tissues, possibly utilizing
the fly tissues as a nutrient source [25]. For S. aureus, it
induces systemic infection in the flies following injection
into the dorsal thorax, wherein S. aureus cells were
found to be present throughout the body of the fly,
followed by fly death [14]. In this study we demonstrated
that the low virulence strains were limited to a localized
infection, but the high virulence MRSA strains prolife-
rated and spread systemically compared with the low
virulence strains. We noted that the growth rate in vivo
does not correlate with that in vitro, either in rich or
minimal medium (Figure 2A-C). Bacterial counts in vari-
ous fly body parts, as well as Gram staining and micro-
scopic examination revealed that less than 1% of the
entire bacterial load was seen in these different body
parts suggesting that most bacteria were probably still
located near or outside the injection sites of the dorsal
thorax, and bacteria likely entered the circulatory system
and subsequently spread to the different fly organs.
However, compared with the low virulence strains, sig-
nificantly more bacterial cells were observed in the
organs and tissues of the flies infected with the high
virulence strains. This observation is further supported
by microscopic and histopathological examination of the
whole fly. It is possible that the bacteria encountered the
host AMPs and phagocytes, and that the immune
response was capable of inhibiting proliferation and fur-
ther spreading of the low virulence strains compared
with the high virulence strains. It was also noticed that
two low virulence strains, CMRSA6-1777 and M92 have
the same in vivo growth but different virulence, which
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For CMRSA2-849, which had the highest cfu counts and
caused the most deaths after 72 hrs, the killing mechan-
isms may be more complex.
To better understand the host-pathogen interactions,
we assessed the host immune response to MRSA strains
having different genetic backgrounds. D. melanogaster
has a well described innate immune system and activa-
tion of the toll and the immune deficiency (IMD) signal-
ling pathways by infection leads to synthesis of AMPs.
These small peptides are primarily produced in the fat
body and secreted into the hemolymph [26]. AMPs have
various properties, including microbicidal activity against
Gram-negative bacteria, Gram-positive bacteria, and/or
fungi. It has been shown that diptericin and cecropin are
active against Gram-negative bacteria while drosomycin
is active against fungi. However, one study showed that
in the wild type flies, S. aureus elicited a strong induc-
tion of AMP genes, including cecropin A, drosomycin,
and diptericin [27]. This study demonstrated that MRSA
strains with different genetic backgrounds are capable of
inducing the expression of these genes, with the highest
expression level at 18 hours, and with a decrease or
stabilization at 24 hours. The high virulence strains did
not suppress AMP gene expression, but rather induced
AMP gene expression to the same extent that low viru-
lence strains did. This finding is in contrast to previous
observations in a P. aeruginosa – D. melanogaster infec-
tion model whereby a virulent P. aeruginosa strain sup-
pressed or poorly elicited AMP gene expression, while
the avirulent strain induced gene expression [28]. In the
current study, the low virulence strain, M92, induced
significantly less cecropin A1 expression at 18 hours
post infection compared with the other strains
(Figure 3C) even though M92 and CMRSA6 are both
the low virulence strains. As described earlier, M92 is a
colonization strain, isolated from health care workers
and has never been associated with infection. This strain
may have developed the ability to tune down the host
immune response thereby facilitating colonization rather
than clearance by the host. Alternatively, this strain may
have lost virulence factors associated with inducing high
levels of cecropin A1 in the flies. The mechanism for
this observation requires further study.
The mechanisms contributing to the virulence of
S. aureus are likely determined by the genetic background
of each strain as well by the specific combination of viru-
lence genes. Previously, we have determined the presence
of 34 virulence genes studied by PCR in MRSA strains, but
no specific genes that were directly associated with the
hypervirulence of USA300, USA400, and CMRSA2 were
identified [6]. The different virulence between these MRSA
strains in the fly model may have resulted from differential
bacterial virulence gene expression, as Loughman et al.have shown that differential bacterial virulence gene
expression can be associated with different clinical out-
comes during human infections [29]. In this study we
determined the in vitro and in vivo expression levels of 5
common bacterial virulence genes, including 2 hemolysins
(hla and hlg) and 3 exoenzymes (sak, hysA and sspA),
involved in invasive S. aureus infection. Our results agreed
with previous studies that hla, hlg, and sak, had higher
gene expression levels in the stationary growth phase for
all strains (Figure 4A) [21-23]. Other studies also noted
that sspA was expressed more in the stationary phase [30],
while hysA was expressed to a lesser degree [31]. Our
results showed that the expression levels of sspA and hysA
differed in the individual strains (Figure 4A), suggesting
that regulation of these gene varies between strains, which
could be related to the specific genetic background. Fur-
ther comparisons demonstrated that the expression of hla
in vivo was significantly higher in all high virulence strains
compared to both low virulence strains although the
opposite results were observed in vitro (Figure 4B,C).
Hemolysin α has been implicated as one of the most
important virulence factors for S. aureus [32], not only in
forming pores on the host cell membrane, but also in
inducing the release of cytokines and chemokines [33].
Vaccination against hemolysin α showed efficient protec-
tion for mice in a S. aureus-induced pneumonia model
[34,35]. A recent study also demonstrated that hemolysin
α contributed to severe skin infection caused by a
USA300 strain in a mouse model, and that vaccination
against hemolysin α provided efficient protection in this
model [36]. Collectively, previous studies and our results
suggest that killing activity in the fly model arises from the
interplay of multiple virulence factors, with hemolysin α
being one of the major factors contributing to the viru-
lence in the model. However, this hypothesis requires con-
firmation in future studies. Additionally, it is necessary to
point out that the fly model is still an invertebrate model
and the virulence in the fly model may not necessarily
reflect the virulence in human infection. For example, as
shown in a previous study [14], agr and sar mutants,
which have reduced virulence in mammalian models
[37,38], did not show significantly attenuated virulence in
the fly model.
Conclusions
Our results demonstrated that the D. melanogaster model
was a useful model for studying the virulence of MRSA,
as MRSA strains with the distinct genetic backgrounds
had different degrees of virulence in the D. melanogaster
model, which may have resulted from the differential
expression of bacterial virulence factors in vivo. These
results are similar to what we observed in the C. elegans
model and, therefore, the fly represents another model for
the high-throughput analysis of S. aureus virulence. We
Wu et al. BMC Microbiology 2012, 12:274 Page 9 of 10
http://www.biomedcentral.com/1471-2180/12/274believe the information obtained from this study provides
new insights into the interactions between bacteria and
the host, but we recognize more studies will be needed to
elucidate the killing mechanism in the fly model.
Authors’ contributions
KW and KZ conceived the idea and designed the overall study. KW
performed experiments. JC, MS, CS and SE contributed to the experimental
design and the analyses of the experimental results. JC and KZ supervised
the overall study. KW and KZ prepared the manuscript. All authors have read,
commented and approved the final manuscript.
Acknowledgement
This work was presented (abstract No. 618) in part at the 13th International
Symposium on Staphylococci and Staphylococcal Infections, Cairns,
Queensland, Australia, 7–10 September 2008. This work was in part
supported by the Alberta Heritage Foundation for Medical Research (grant
to KZ and JC) and the Centre for Antimicrobial Resistance (CAR), Alberta
Health Services.
Author details
1Department of Pathology & Laboratory Medicine, University of Calgary, 3330
Hospital Drive NW, Calgary, AB T2N 4N1, Canada. 2Department of
Microbiology, Immunology and Infectious Diseases, University of Calgary,
Calgary, AB, Canada. 3Department of Medicine, University of Calgary, Calgary,
AB, Canada. 4The Calvin, Phoebe and Joan Snyder Institute for Chronic
Diseases, University of Calgary, Calgary, AB, Canada. 5Centre for Antimicrobial
Resistance, Alberta Health Services/Calgary Laboratory Services/University of
Calgary, Calgary, AB, Canada. 6Farncombe Family Digestive Health Research
Institute, Departments of Medicine and Biochemistry and Biomedical
Sciences, McMaster University, Hamilton, ON, Canada. 7Department of
Medicine, University of Western Ontario, London, ON, Canada. 8Department
of Microbiology & Infectious Disease, University of Western Ontario, London,
ON, Canada.
Received: 3 November 2012 Accepted: 20 November 2012
Published: 23 November 2012
References
1. Crossley KB, Jefferson KK, Archer GL, Fowler VG Jr: The staphylococci in
human disease. 2nd edition. West Sussex, UK: Wiley-Blackwell; 2009.
2. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH,
Lynfield R, Dumyati G, Townes JM, et al: Invasive methicillin-resistant
Staphylococcus aureus infections in the United States. JAMA 2007, 298
(15):1763–1771.
3. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella
SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, et al: Insights into
mechanisms used by Staphylococcus aureus to avoid destruction by
human neutrophils. J Immunol 2005, 175(6):3907–3919.
4. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J,
Daum RS: Comparison of virulence in community-associated methicillin-
resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat
model of pneumonia. J Infect Dis 2008, 198(4):561–570.
5. Chambers HF, Deleo FR: Waves of resistance: Staphylococcus aureus in the
antibiotic era. Nat Rev Microbiol 2009, 7(9):629–641.
6. Wu K, Conly J, McClure JA, Elsayed S, Louie T, Zhang K: Caenorhabditis
elegans as a host model for community-associated methicillin-resistant
Staphylococcus aureus. Clin Microbiol Infect 2010, 16(3):245–254.
7. Conly J, Wu K, Zhang K, Shurgold J, Gravel D, Campbell J, Mulvey M, Simor
A, Byrce E, Loeb M, et al: Comparison of Hospital vs Community Associated
Methicillin-Resistant Staphylococcus aureus Strains (MRSA) in the Canadian
Nosocomial Infection Surveillance Program from 1995–2005: Correlation of
Clinical Invasiveness with a Caenorhabditus elegans Host Model [Abstract].
The 14th International Symposium on Staphylococci and Staphylococcal
Infection: 2010. (Bath, United Kingdom), 159: abstract 148.
8. Ferrandon D, Imler JL, Hetru C, Hoffmann JA: The Drosophila systemic
immune response: sensing and signalling during bacterial and fungal
infections. Nat Rev Immunol 2007, 7(11):862–874.
9. D'Argenio DA, Gallagher LA, Berg CA, Manoil C: Drosophila as a model host
for Pseudomonas aeruginosa infection. J Bacteriol 2001, 183(4):1466–1471.10. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG:
Discerning the complexity of community interactions using a Drosophila
model of polymicrobial infections. PLoS Pathog 2008, 4(10):e1000184.
11. Dionne MS, Ghori N, Schneider DS: Drosophila melanogaster is a
genetically tractable model host for Mycobacterium marinum. Infect
Immun 2003, 71(6):3540–3550.
12. Mansfield BE, Dionne MS, Schneider DS, Freitag NE: Exploration of host-
pathogen interactions using Listeria monocytogenes and Drosophila
melanogaster. Cell Microbiol 2003, 5(12):901–911.
13. Brandt SM, Dionne MS, Khush RS, Pham LN, Vigdal TJ, Schneider DS:
Secreted bacterial effectors and host-produced Eiger/TNF drive death in
a Salmonella-infected fruit fly. PLoS Biol 2004, 2(12):e418.
14. Needham AJ, Kibart M, Crossley H, Ingham PW, Foster SJ: Drosophila
melanogaster as a model host for Staphylococcus aureus infection.
Microbiology 2004, 150(Pt 7):2347–2355.
15. Christianson S, Golding GR, Campbell J, Mulvey MR: Comparative genomics
of Canadian epidemic lineages of methicillin-resistant Staphylococcus
aureus. J Clin Microbiol 2007, 45(6):1904–1911.
16. Chugani SA, Whiteley M, Lee KM, D'Argenio D, Manoil C, Greenberg EP:
QscR, a modulator of quorum-sensing signal synthesis and virulence in
Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2001, 98(5):2752–2757.
17. Fehlbaum P, Bulet P, Michaut L, Lagueux M, Broekaert WF, Hetru C,
Hoffmann JA: Insect immunity. Septic injury of Drosophila induces the
synthesis of a potent antifungal peptide with sequence homology to
plant antifungal peptides. J Biol Chem 1994, 269(52):33159–33163.
18. Romeo Y, Lemaitre B: Drosophila immunity: methods for monitoring the
activity of Toll and Imd signaling pathways. Methods Mol Biol 2008,
415:379–394.
19. Kenny JG, Ward D, Josefsson E, Jonsson IM, Hinds J, Rees HH, Lindsay JA,
Tarkowski A, Horsburgh MJ: The Staphylococcus aureus response to
unsaturated long chain free fatty acids: survival mechanisms and
virulence implications. PLoS One 2009, 4(2):e4344.
20. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods
2001, 25(4):402–408.
21. Nariya H, Izaki K, Kamio Y: The C-terminal region of the S component of
staphylococcal leukocidin is essential for the biological activity of the
toxin. FEBS Lett 1993, 329(1–2):219–222.
22. Yamazaki K, Kato F, Kamio Y, Kaneko J: Expression of gamma-hemolysin
regulated by sae in Staphylococcus aureus strain Smith 5R. FEMS Microbiol
Lett 2006, 259(2):174–180.
23. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP:
Regulation of exoprotein gene expression in Staphylococcus aureus by
agar. Mol Gen Genet 1986, 202(1):58–61.
24. Irazoqui JE, Urbach JM, Ausubel FM: Evolution of host innate defence:
insights from Caenorhabditis elegans and primitive invertebrates. Nat Rev
Immunol 2010, 10(1):47–58.
25. Lau GW, Goumnerov BC, Walendziewicz CL, Hewitson J, Xiao W, Mahajan-
Miklos S, Tompkins RG, Perkins LA, Rahme LG: The Drosophila melanogaster
toll pathway participates in resistance to infection by the gram-negative
human pathogen Pseudomonas aeruginosa. Infect Immun 2003, 71
(7):4059–4066.
26. Imler JL, Hoffmann JA: Signaling mechanisms in the antimicrobial host
defense of Drosophila. Curr Opin Microbiol 2000, 3(1):16–22.
27. Hedengren-Olcott M, Olcott MC, Mooney DT, Ekengren S, Geller BL, Taylor
BJ: Differential activation of the NF-kappaB-like factors Relish and Dif in
Drosophila melanogaster by fungi and Gram-positive bacteria. J Biol
Chem 2004, 279(20):21121–21127.
28. Apidianakis Y, Mindrinos MN, Xiao W, Lau GW, Baldini RL, Davis RW, Rahme
LG: Profiling early infection responses: Pseudomonas aeruginosa eludes
host defenses by suppressing antimicrobial peptide gene expression.
Proc Natl Acad Sci U S A 2005, 102(7):2573–2578.
29. Loughman JA, Fritz SA, Storch GA, Hunstad DA: Virulence gene expression
in human community-acquired Staphylococcus aureus infection. J Infect
Dis 2009, 199(3):294–301.
30. Gustafsson E, Oscarsson J: Maximal transcription of aur (aureolysin) and sspA
(serine protease) in Staphylococcus aureus requires staphylococcal
accessory regulator R (sarR) activity. FEMS Microbiol Lett 2008, 284(2):158–164.
31. Makris G, Wright JD, Ingham E, Holland KT: The hyaluronate lyase of
Staphylococcus aureus - a virulence factor? Microbiology 2004,
150(Pt 6):2005–2013.
Wu et al. BMC Microbiology 2012, 12:274 Page 10 of 10
http://www.biomedcentral.com/1471-2180/12/27432. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O: Poring over
pores: alpha-hemolysin and Panton-Valentine leukocidin in
Staphylococcus aureus pneumonia. Nat Med 2007, 13(12):1405–1406.
33. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M, Nizet V,
Eckmann L: NOD2 contributes to cutaneous defense against
Staphylococcus aureus through alpha-toxin-dependent innate immune
activation. Proc Natl Acad Sci U S A 2009, 106(31):12873–12878.
34. Stranger-Jones YK, Bae T, Schneewind O: Vaccine assembly from surface
proteins of Staphylococcus aureus. Proc Natl Acad Sci U S A 2006, 103
(45):16942–16947.
35. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O,
DeLeo FR: Panton-Valentine leukocidin is not a virulence determinant in
murine models of community-associated methicillin-resistant
Staphylococcus aureus disease. J Infect Dis 2008, 198(8):1166–1170.
36. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR,
Braughton KR, Schneewind O, DeLeo FR: Targeting of alpha-hemolysin by
active or passive immunization decreases severity of USA300 skin
infection in a mouse model. J Infect Dis 2010, 202(7):1050–1058.
37. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A: The accessory
gene regulator (agr) controls Staphylococcus aureus virulence in a
murine arthritis model. Infect Immun 1993, 61(9):3879–3885.
38. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, Bayer
AS: Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus
in the rabbit model of endocarditis. J Clin Invest 1994, 94(5):1815–1822.
doi:10.1186/1471-2180-12-274
Cite this article as: Wu et al.: Assessment of virulence diversity of
methicillin-resistant Staphylococcus aureus strains with a Drosophila
melanogaster infection model. BMC Microbiology 2012 12:274.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
